MiYOSMART

What is short-sightedness (myopia)?

Nothing is more important than the health and wellbeing of your child, now and in the future, you want to see your child thrive and that’s the key: seeing. You may have noticed your child struggling to see clearly at a distance, making it harder to concentrate at school and have a fulfilling experience at play. Your child may have myopia.

Myopia is a global concern

The incidence of myopia is expected to increase significantly as lifestyle changes, with children taking part in more near-work activities like using digital devices, studying, reading and spending less time outdoors. Hereditary, behavioural and environmental factors also play a part.

Being able to have your child’s myopia diagnosed early not only corrects their vision now, but can help slow the progression of myopia and preserve their vision and eye health for the future.

A breakthrough spectacle lens

This revolutionary spectacle lens based on patented Defocus Incorporated Multiple Segments (D.I.M.S.) Technology was developed in cooperation with The Hong Kong Polytechnic University in 2014. MiYOSMART is easy to fit, just like regular single vision lens. There are no limitations for the frame choice.

How does MiYOSMART work?

Cutting edge research conducted by The Hong Kong Polytechnic University showed that myopia progression can be managed by providing clear vision and constant myopic defocus simultaneously.

Designed to fit a child’s active life

MiYOSMART comes with an easy-to-wipe special anti-reflective, durable coating. With its Eye Shield, young patients get the added assurance of an impact resistant material and UV protection.

MiYOSMART’s Eye Shield

  • Impact resistant
  • Thin and light
  • Comes with UV protection

Why MiYOSMART?

A child-friendly, safe and effective non-invasive method

During the 2 year clinical trial no adverse event was reported that would have led to discontinuation of the treatment.

The lens is a very effective method to manage myopia and can be fitted to a child at any age like regular single vision lens.

An award-winning, breakthrough ophthalmic lens, patented with D.I.M.S. technology

MiYOSMART’s efficacy is based on patent protected D.I.M.S. islands creating myopic defocus effect.

In 2018, the MiYOSMART lens won the Gold Prize, Grand Award & Special Gold Award Int’l Exhibition of Inventions of Geneva, Switzerland. In 2020, it won the Silmo d’Or Award in the Vision category at the Silmo Paris Optical Fair.

Appreciated by parents

MiYOSMART has data-driven proof of its effectiveness, with more than 500K patients/wearers.

Parents are happy with the value for money.

They appreciated the Eye Care Professional 6 month protocol and follow-up actions.

*Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. British Journal of Ophthalmology. Published Online First: 29 May 2019. doi: 10.1136/bjophthalmol-2018-313739 1 Holden B.A., Fricke T.R., Wilson D.A., Jong M., Naidoo K.S., Sankaridurg P., Wong T.Y., Naduvilath T.J., Resniko_ S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. American Academy of Ophthalmology. 05/2016, vol.123, no. 5, p.1036–1042. https://doi.org/10.1016/j.ophtha.2016.01.006. 2 years of data shows a 60% slowdown of myopia progression on average—myopia progression (SER) slowed by 59% and axial elongation (AL) decreased by 60% compared with those wearing single vision lenses. Myopia progression was completely stopped in 21.5% of those wearing MiYOSMART. The 2 year randomized controlled trial involved 160 children aged 8 to 13
1 Brien Holden Vision Institute; 2 Shanghai Eye Disease Prevention and Treatment Center https://guidelines.brienholdenvision.org, accessed 16.08.1018.
2 Lam CSY, Tang WC, Lee RPK, Chun RKM, To CH. A randomized clinical trial for myopia control – use of myopic defocus spectacle lens. 8th International Congress of Behavioral Optometry (ICBO), 26-29 of April 2018. Sydney, Australia. 8Sankaridurg P1, Tilia D1, Morton M1, Weng R1, Jong M1, Zhu F2. Guidelines for Myopia Management.